Hi Longecity,
I'm a regular reader of Patrick Cox's Tech Digest, which is a weekly newsletter devoted to regenerative medicine and ageing research, and is well worth checking out as he gets quite a bit of insider knowledge. Anyway, the latest instalment caught my eye and if what it says is true, could be revolutionary. I don't have permission to reproduce the entire post, so I have only included the opening few paragraphs below. I suggest you follow the link to the original post underneath and read the entire post. Most enlightening.
Chris
BY PATRICK COX
JANUARY 8, 2018
Dear Reader,
Last week, the world got the first peer-reviewed look at what I believe is the future of medicine. Specifically, I’m talking about the discovery that the COX7A1 gene is a switch that controls embryonic healing processes.
The genes that built you from a few undifferentiated embryonic cells are still in your genome. These “developmental” genes are largely dormant, but they’re still there.
In the last year, about half a dozen institutions have announced breakthroughs in the reactivation of these genes. However, not much has been revealed about what’s happening on the genomic level.
That’s why the publication of a paper in the respected journal Oncotarget is historic. The article is titled, “Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells.”
The paper presents the culmination of research I’ve been writing about for several years. Having pioneered work on the immortalizing enzyme telomerase and pluripotent stem cell medicine, Michael West, CEO of both BioTime and its subsidiary, AgeX Therapeutics, has taken regenerative medicine to the next level.
http://www.mauldinec...hange-the-world